Patents by Inventor Anna Maria Teti

Anna Maria Teti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210128472
    Abstract: The present invention relates to RANKL+ cellular vesicles isolated from osteoblastic lineage cells, optionally immortalised, their use for the therapeutic treatment of bone pathologies and for diagnostic purposes, and processes for the production of said vesicles.
    Type: Application
    Filed: December 18, 2020
    Publication date: May 6, 2021
    Inventors: Maurizio MURACA, Alfredo CAPPARIELLO, Anna Maria TETI
  • Patent number: 10881611
    Abstract: The present invention relates to RANKL+ cellular vesicles isolated from osteoblastic lineage cells, optionally immortalised, their use for the therapeutic treatment of bone pathologies and for diagnostic purposes, and processes for the production of said vesicles.
    Type: Grant
    Filed: June 16, 2016
    Date of Patent: January 5, 2021
    Assignee: Fondazione Città Della Speranza—Onlus
    Inventors: Maurizio Muraca, Alfredo Cappariello, Anna Maria Teti
  • Patent number: 10450571
    Abstract: The present invention lies in the field of molecules known as “small interfering RNA” with therapeutic applications. siRNAs have the ability to reduce gene expression in an extremely specific way (1). These are small sequences of double-strand RNA, normally used in laboratory to modify cell function, which revolutionized cell biology by allowing previously precluded molecular manipulations.
    Type: Grant
    Filed: May 21, 2015
    Date of Patent: October 22, 2019
    Assignee: Università degli Studi dell'Aquila
    Inventors: Anna Maria Teti, Nadia Rucci, Mattia Capulli, Antonio Maurizi
  • Publication number: 20180193263
    Abstract: The present invention relates to RANKL+ cellular vesicles isolated from osteoblastic lineage cells, optionally immortalised, their use for the therapeutic treatment of bone pathologies and for diagnostic purposes, and processes for the production of said vesicles.
    Type: Application
    Filed: June 16, 2016
    Publication date: July 12, 2018
    Inventors: Maurizio MURACA, Alfredo CAPPARIELLO, Anna Maria TETI
  • Publication number: 20170101644
    Abstract: The present invention lies in the field of molecules known as “small interfering RNA” with therapeutic applications. siRNAs have the ability to reduce gene expression in an extremely specific way (1). These are small sequences of double-strand RNA, normally used in laboratory to modify cell function, which revolutionized cell biology by allowing previously precluded molecular manipulations.
    Type: Application
    Filed: May 21, 2015
    Publication date: April 13, 2017
    Applicant: Universita degli Studi dell"Aquilla
    Inventors: Anna Maria TETI, Nadia RUCCI, Mattia CAPULLI, Antonio MAURIZI
  • Publication number: 20030176384
    Abstract: The present invention relates to an antisense oligonucleotide or a derivative thereof which has a sequence that corresponds to a part of a nucleic acid which encodes an integrin &agr;v subunit and which has the ability to induce apoptosis, the preparation and the use thereof.
    Type: Application
    Filed: November 6, 2002
    Publication date: September 18, 2003
    Inventors: Eugen Uhlmann, Anuschirwan Peyman, Anna Maria Teti, Ida Villanova